IL-1β regulation of Zika-mediated adverse perinatal outcomes
IL-1β regulation of Zika-mediated adverse perinatal outcomes
批准号:
10189676
负责人:
IRINA BURD
金额:
$59.74万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-21 至 2023-06-30
关键词:
AddressAdverse effectsAffectAfrican AmericanAntiviral AgentsAsiansBirthBrainCommunicationCongenital AbnormalityDataDevelopmentDiseaseDoseEmbryo TransferFamilyFemaleFetal DevelopmentFetusFlaviviridaeGeneticGestational AgeImmunocompetentImmunomodulatorsInfectionInflammasomeInflammationInflammatoryInterleukin-1 ReceptorsInterleukin-1 betaInterventionKineretKineticsLeadMediatingMicrocephalyModelingMouse StrainsNatureNeonatalNervous System TraumaNeurologic DeficitOutcomePathogenesisPerinatalPerinatal Brain InjuryPharmaceutical PreparationsPharmacologyPlacentaPregnancyProblem behaviorProductionPublishingRNA VirusesReceptor SignalingRecombinantsRegulationResearch ProposalsRoleSex DifferencesSignal TransductionTestingTherapeutic InterventionThinnessTranslational ResearchVaccinesViral Load resultViral PathogenesisWild Type MouseZIKAZIKV infectionZika Virusadverse outcomebrain abnormalitiescongenital infectionearly pregnancyexperimental studyfetalfetal brain injuryfetal infectionimmunopathologyimprovedin uterointrauterine infectionintrauterine inflammationmouse modelneurobehavioralneurotoxicitynoveloffspringperinatal medicineperinatal outcomesplacental infectionpregnantprenatal exposurereceptorreceptor bindingresponsesextherapeutically effectivetool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
SUMMARY
Zika virus (ZIKV) infection of pregnant females results in congenital infection of offspring and long-term
developmental birth defects. Using an immunocompetent mouse model that we developed (published in
Nature Communications), we have shown that intrauterine infection with either African, American, or Asian
strains of ZIKV during early, but not late, pregnancy causes infection of the placenta and fetuses, placental
inflammation, neonatal cortical thinning, and short-term neurologic deficits in offspring. More recently, we have
demonstrated that placental IL-1β concentrations are elevated in ZIKV-infected dams, and we can reverse the
ZIKV-associated short-term neurobehavioral sequelae in offspring by blocking IL-1 receptor signaling during
the infection. We hypothesize that placental inflammation following intrauterine ZIKV infection causes perinatal
neurological injury, which can then be reversed by targeting maternal IL-1β signaling. While most ZIKV
interventions focus on antivirals and vaccines to limit perinatal ZIKV infection, to date no studies have
considered the role of maternal and placental inflammation as a mechanism mediating long-term adverse
perinatal outcomes following ZIKV infection. Specific Aim 1 will assess the mechanisms mediating elevated IL-
1β signaling in the placenta at different gestational ages following ZIKV infection, the long-term downstream
effects of the placental immunopathology and placental IL-1β signaling, and whether these effects are sex-
specific. In particular, Aim 1 will determine how placental inflammasome activation, IL-1β release, or
engagement of the IL-1 receptor lead to adverse perinatal outcomes. Specific Aim 2 will examine the
importance of maternal as opposed to fetal IL-1β signaling in the pathogenesis of perinatal brain injury
following ZIKV infection. Using embryo transfer of IL-1β signaling deficient and wild type mouse strains, Aim 2
will assess whether IL-1β activity of maternal origin is critical for sex-specific fetal brain injury. Our novel
translational research proposal, utilizing a ZIKV model that we developed, will have a significant impact on
perinatal medicine as it will lead to a better understanding of the role of placental inflammation in the
pathogenesis of fetal congenital diseases caused by infection or other inflammatory states during pregnancy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Placental Serum Amyloid A as a Therapeutic Target to Prevent Preterm Birth and Prematurity Related Morbidity
-
批准号:10742411
-
项目类别:
-
资助金额:$42.49万
-
财政年份:2023
-
负责人:IRINA BURD
-
依托单位:
IL-1B regulation of Zika-Mediated adverse perinatal outcomes
-
批准号:10782381
-
项目类别:
-
资助金额:$32.05万
-
财政年份:2023
-
负责人:IRINA BURD
-
依托单位:
Nanomedicine-based approach for characterizing the epigenome in prevention of inflammation-induced preterm birth.
-
批准号:10586624
-
项目类别:
-
资助金额:$62.44万
-
财政年份:2022
-
负责人:IRINA BURD
-
依托单位:
Nanomedicine approaches for prevention of inflammation-induced preterm birth
-
批准号:10392489
-
项目类别:
-
资助金额:$62.97万
-
财政年份:2021
-
负责人:IRINA BURD
-
依托单位:
7/24 Healthy Brain and Child Development National Consortium
-
批准号:10380210
-
项目类别:
-
资助金额:$96.91万
-
财政年份:2021
-
负责人:IRINA BURD
-
依托单位:
Nanomedicine approaches for prevention of inflammation-induced preterm birth
-
批准号:10591822
-
项目类别:
-
资助金额:$7.22万
-
财政年份:2021
-
负责人:IRINA BURD
-
依托单位:
Nanomedicine approaches for prevention of inflammation-induced preterm birth
-
批准号:10211305
-
项目类别:
-
资助金额:$62.97万
-
财政年份:2021
-
负责人:IRINA BURD
-
依托单位:
Nanomedicine approaches for prevention of inflammation-induced preterm birth
-
批准号:10406669
-
项目类别:
-
资助金额:$7.22万
-
财政年份:2021
-
负责人:IRINA BURD
-
依托单位:
Nanomedicine approaches for prevention of inflammation-induced preterm birth
-
批准号:10592363
-
项目类别:
-
资助金额:$62.97万
-
财政年份:2021
-
负责人:IRINA BURD
-
依托单位:
Placental determinants of neonatal immune function in maternal HIV infection
-
批准号:9900843
-
项目类别:
-
资助金额:$21.25万
-
财政年份:2019
-
负责人:IRINA BURD
-
依托单位:
IL-1β regulation of Zika-mediated adverse perinatal outcomes
-
批准号:10438667
-
项目类别:
-
资助金额:$13.81万
-
财政年份:2018
-
负责人:IRINA BURD
-
依托单位:
IL-1β regulation of Zika-mediated adverse perinatal outcomes
-
批准号:9789911
-
项目类别:
-
资助金额:$60.95万
-
财政年份:2018
-
负责人:IRINA BURD
-
依托单位:
IL-1beta regulation of perinatal brain injury
-
批准号:8519500
-
项目类别:
-
资助金额:$13.68万
-
财政年份:2012
-
负责人:IRINA BURD
-
依托单位:
IL-1beta regulation of perinatal brain injury
-
批准号:8353189
-
项目类别:
-
资助金额:$13.68万
-
财政年份:2012
-
负责人:IRINA BURD
-
依托单位:
IL-1beta regulation of perinatal brain injury
-
批准号:8657474
-
项目类别:
-
资助金额:$13.68万
-
财政年份:2012
-
负责人:IRINA BURD
-
依托单位:
IL-1beta regulation of perinatal brain injury
-
批准号:8841392
-
项目类别:
-
资助金额:$13.68万
-
财政年份:2012
-
负责人:IRINA BURD
-
依托单位:
海外基金